Beta-thalassemia—a serious blood disorder requiring ongoing care
Beta-thalassemia is a rare, inherited blood disorder that reduces the body’s ability to produce functional hemoglobin. Many patients require ongoing transfusions, creating a significant long-term treatment burden.
Our therapeutic approach is designed to address the underlying genetic cause of the disease, with the goal of reducing or eliminating the need for ongoing transfusions.
Discover our one-time treatment for beta-thalassemia
Patient Spotlight
Meet Priyanka, living with beta-thalassemia, who continues to build a full life while advocating for greater awareness and support.
“I try not to let thalassemia hold me back. I try to have a somewhat normal life.”
Patient Spotlight
Meet Priyanka, living with beta-thalassemia, who continues to build a full life while advocating for greater awareness and support.
“I try not to let thalassemia hold me back. I try to have a somewhat normal life.”
Beta-thalassemia Support
Managing beta-thalassemia often involves ongoing care and long-term treatment. The organization in the link below provides helpful resources, support, and connections for individuals and families navigating the condition.
You Are Now Leaving Genetix Biotherapeutics
You are about to visit a website operated by an independent organization that is not affiliated with Genetix Biotherapeutics. Genetix does not endorse and is not responsible for the content, privacy practices, or policies of external websites. Links are provided for informational purposes only.
Continue Exploring
Find a Qualified Treatment Center and take the next steps towards care
Explore our white-glove support designed for patients navigating the treatment journey